Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
US9895436B2 · kind B2 · utility
2Cited by
45References
69Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 12, 2013 |
| Grant date | Feb 20, 2018 |
| Priority date | — |
| Expiry date | Nov 12, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55577
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and immunogenic compositions against HSV-2. The antigens can be used therapeutically or prophylactically.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.